Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,270 | In Stock | |
50 mg | $2,980 | In Stock | |
100 mg | $4,000 | In Stock |
Description | SCH 563705 is an effective and orally available CXCR2 and CXCR1 antagonist (IC50s: 1.3 nM, 7.3 nM and Kis of 1 and 3 nM, respectively). |
Targets&IC50 | CXCR2 (mouse):5.2 nM, CXCR1:3 nM (ki), CXCR1:7.3 nM, CXCR2:1 nM (ki), CXCR2:1.3 nM |
In vitro | SCH 563705 potently inhibits mouse CXCR2 (IC50 = 5.2 nM). SCH 563705 displays potent inhibition against both Gro-a and IL-8 induced human neutrophil migration (chemotaxis IC50 = 0.5 nM, against 30 nM of Gro-a; chemotaxis IC50 = 37 nM, against 3 nM of IL-8) [1][2]. |
In vivo | SCH 563705 exhibits favorable oral pharmacokinetic profiles in rats, mice, monkeys, and dogs. Treatment with SCH 563705 (3-30 mg/kg p.o) leads to a dose-dependent increase in plasma CXCL1 levels. Additionally, SCH 563705 (50 mg/kg p.o) reduces blood Ly6G+ Ly6C+ neutrophil frequency without altering Ly6GLy6Chi monocyte levels [1][2]. |
Molecular Weight | 425.48 |
Formula | C23H27N3O5 |
Cas No. | 473728-58-4 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 30 mg/mL (70.51 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.